CASI Pharmaceuticals, Inc. (CASI)
NASDAQ: CASI · IEX Real-Time Price · USD
2.240
-0.010 (-0.44%)
Apr 17, 2024, 4:00 PM EDT - Market closed
CASI Pharmaceuticals Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for CASI stock has a target of 12, which predicts an increase of 435.71% from the current stock price of 2.24.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 15, 2023.
Analyst Ratings
According to 1 stock analyst, the rating for CASI is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $12 | Strong Buy | Maintains | $10 → $12 | +435.71% | Nov 15, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +346.43% | Aug 14, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +346.43% | May 22, 2023 |
| BTIG | BTIG | Strong Buy Maintains $21 → $10 | Strong Buy | Maintains | $21 → $10 | +346.43% | Nov 16, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $12 → $10 | Strong Buy | Maintains | $12 → $10 | +346.43% | Nov 15, 2022 |
Financial Forecast
Revenue This Year
67.85M
from 33.88M
Increased by 100.27%
Revenue Next Year
60.35M
from 67.85M
Decreased by -11.05%
EPS This Year
-1.07
from -2.02
EPS Next Year
n/a
from -1.07
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 62.1M | 120.5M | 123.9M | 150.6M | 179.6M |
| Avg | 60.4M | 91.0M | 120.4M | 146.3M | 174.5M |
| Low | 58.0M | 62.4M | 115.7M | 140.6M | 167.7M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 83.4% | 99.6% | 36.2% | 25.1% | 22.8% |
| Avg | 78.1% | 50.7% | 32.3% | 21.5% | 19.3% |
| Low | 71.2% | 3.3% | 27.2% | 16.8% | 14.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | -1.22 | 0.72 | 1.00 | 1.35 |
| Avg | - | -1.18 | 0.70 | 0.97 | 1.32 |
| Low | - | -1.14 | 0.68 | 0.93 | 1.26 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | 41.7% | 39.8% |
| Avg | - | - | - | 37.7% | 35.8% |
| Low | - | - | - | 32.3% | 30.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.